We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





Real-Time Imaging Shows How SARS-CoV-2 Attacks Human Cells

By HospiMedica International staff writers
Posted on 10 Sep 2020
Print article
Image: Real-Time Imaging Shows How SARS-CoV-2 Attacks Human Cells (Photo courtesy of NIAID)
Image: Real-Time Imaging Shows How SARS-CoV-2 Attacks Human Cells (Photo courtesy of NIAID)
Scientists have used imaging assays to view the binding of the spike, or protein, on the SARS-CoV-2 virus to ACE 2 (angiotensin converting enzyme 2) and subsequent internalization that takes place when ACE2 and the spike protein interact in real time.

A report by Science X on Phys.org explains how scientists from the NIH’s National Center for Advancing Translational Sciences (NCATS Bethesda, MA, USA) performed real-time imaging to show how SARS-CoV-2 attacks human cells. Researchers around the world have been trying to understand how SARS-CoV-2 interacts with and penetrates host cells in order to block the stage and halt the onset of COVID19. The SARS-CoV-2 virus uses spike proteins to mobilize its viral DNA into a host cell while the ACE2 receptors, which are human cell proteins, open the door for the attack. In previous studies, researchers had been able to tag these receptor proteins with a green fluorescent protein to image their movements. However, details about the spike protein interactions have been gathered mainly from biochemical or proximity assays and tests with proteins and parts of proteins taken from the virus - "pseudo-viro-particles" according to the Phys.org report. As a result of the lack of fluorescent labeling of these viral proteins, researchers have been unable to perform imaging of their role in the ACE2 receptor binding and subsequent internalization - endocytosis.

Scientists at NCATS who had already begun working on various imaging assays for cancers, viruses and lysosomal storage diseases, used their expertise with nanoparticles for cellular delivery and biosensing to aid in the search for COVID-19 drug treatments. The team started looking at potential ways of applying the protein-nanostructure conjugation techniques. With two proteins that share a binding affinity - a quantum dot attached to one and a fluorescing nanoparticle attached to the other - binding between the two proteins brought the nanostructures close enough for energy transfer between them. The resulting fluorescence quenching allowed the scientists to monitor the protein binding, states the Phys.org report.

The scientists then went on to develop a "pseudovirion" with the potent parts of SARS-CoV-2 spike proteins (where the receptor binding domain is situated) attached to the quantum dot in such a way that the spike proteins continue to attack and penetrate cells similar to an active virus. In order to watch the pseudovirion interacting with ACE2 in a real cell, the quantum dot on the pseudovirion was required to be engineered for emitting at a wavelength that was simple to distinguish from the green fluorescent protein on ACE2, as against optimizing nanoparticle quenching. Using the two clear signals, the NCATS scientists could track the binding of the two proteins and subsequent endocytosis. The team could also see that the binding and endocytosis was halted in the presence of two test antibodies.

"What we're doing here is actually visualizing binding of the spike to ACE 2 (angiotensin converting enzyme 2)," Kirill Gorshkov a research scientist at NCATS told Phys.org. "You can actually see that happen in real time. That's the beauty of this assay and that's why we think it will be important for drug screening."

Related Links:
National Center for Advancing Translational Sciences

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Transvaginal Tube
LiNA McCartney Tube

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.